Sunday, August 29- Virtual Conference
LIVE SESSIONS
Please note that all times below refer to the Indian Standard Time zone.
OPENING SESSION | 08:30- 08:55 hours
Rare disease policy and implications in IEM
Dr. Madhulika Kabra
India
Chair: Dr. Radha Rama Devi
India
CONCURRENT SESSION 3 | 09:00 - 11:05 hours
CO3: Building strategies for IEM patient cohorts and follow up
Chairs: Dr. Kaushik Mandal
India
CO3.1: Challeges in the treatment of patient with Gaucher disease (9:00-9:25)
Dr. Mamta Muranjan
India
CO3.2: Ultra-rare cardiac variant in Gaucher disease: type IIIC, our experience (9:25- 9:50)
Dr. Meenakshi Bhat
India
Co3.3: Follow up of patients with Treatable Inborn Error of Metabolism (9:50- 10:15)
Dr. Inusha Panigrahi
India
CO3.4: Alkaptonuria: Our experience at CMC Vellore ( 10:15- 10:40)
Dr. Sumita Danda
India
CO3.5: MPS type IV: management and follow-up (10:40- 11:05)
Dr. Sujatha Jagdeesh
India
CONCURRENT SESSION 4 | 09:00 - 11:05 hours
CO4: Enzymatic, nutritional and dietic treatment approaches
Chairs: Dr. Parag Dagli
India
CO4.1: B complex vitamins in IEM treatment (9:00- 9:25)
Dr. Koumudi Godbole
India
CO4.2: Nutrition in carbohydrate metabolic disorders (9:25 -9:50)
Dr. Suvarna Magar
India
CO4.3: Vitamin Responsive Epilepsy and Epilepsy Encephalopathy in IEM disorders (9:50- 10:15)
Dr. Harsh Patel
India
CO4.4: Effect of genotype on phenotype and challenges in treating MPS children (10:15- 10:40)
Dr. Prajnya Ranganathan
India
CO4.5: Management of (Intermediary) IEMs in the Molecular era (10:40- 11:05)
Dr. Chaitanya Datar
India
TEA BREAK| 10 mins
WORKSHOP 2 | 11:15- 12: 20 hours
Interpreting next generation sequencing data
Dr. Sridhar Sivasubbu
India
Chair: Dr. Harsh Sheth
India
LUNCH BREAK | 12:20 - 12:50 hours
VIRTUAL POSTER PRESENTATION | 12:50 - 14:20 hours
Judges: Dr. Ashwin Dalal and Dr. Alpa Dherai | Moderator: Dr. Harsh Sheth
SWITCHING ROOMS FOR PLENARY SESSION - 10 mins
PLENARY SESSION 3 | 14:30 - 16:00 hours
PL3: Mechanistic understanding of IEMs
Chairs: Dr. Uma Ramaswamy
India
PL3.1: Adult onset IEMs (14:30- 15:00)
Prof. Sir John Burn
UK
PL3.2: Lysosomal Function and Dysfunction with relevance to LSDs (15:00- 15:30)
Dr. Ashok Vellodi
UK
PL3.3: An overview of Liver Gene therapy and UCDs (15:30- 16:00)
Prof. Julien Baruteau
UK
TEA BREAK- 15 mins
CONCURRENT SESSION 5 | 16:10 - 17:50 hours
CO5: IEM Disorders: Biochemical diagnostic strategies
Chairs: Dr. Harsuti Shah
India
CO5.1: Clinical diagnosis and management of cystic fibrosis (16:10- 16:35)
Dr. Khanjan Shah
India
CO5.2: How and when to suspect an IEM and its management (16:35- 17:00)
Dr. Sunita Bijarnia
India
CO5.3: Small molecule IEM disorders (17:00- 17:25)
Dr. Neerja Gupta
India
CO5.4: TMS vs GC/MS in IEM Screening & Diagnosis- Benefits & Limitations (17:25 -17:50)
Dr. Usha Dave
India
CONCURRENT SESSION 6 | 16:10 - 17:50 hours
CO6: Going forward in detecting and treating IEMs
Chairs: Dr. Udaya Kotecha
India
CO6.1: When to suspect, diagnosis and Management of mitochondrial disorders (16:10- 16:35)
Prof V Raju
India
CO6.2: CAH an under diagnosed IEM: Our experience (16:35- 17:00)
Dr. Shalmi Mehta
India
CO6.3: When to suspect GSDs and its management (17:00- 17:25)
Dr. Madhulika Kabra
India
CO6.4: Repurposing Natural Products following the principles of Pharmacology with focus on Gaucher disease and ALD (17:25- 17:50)
Dr. Reena Kartha
USA
SWITCHING ROOMS FOR CONCLUDING SESSION- 5 mins
CONFERENCE CONCLUSION | 18:00 - 18:15 hours
Prize distribution and important announcements (18:00- 18:07)
Dr. Jayesh Sheth and Dr. Radha Rama Devi
Vote of thanks (18:07- 18:15)
Dr. Harsh Sheth